Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

[Quadrivalent influenza vaccine: What is changed and what are the benefits?]

Mosnier A, Launay O, Martinez L, Gavazzi G, Josset L, Crepey P, Hannoun C, Weil-Olivier C, Gaillat J.

Presse Med. 2018 Oct;47(10):842-853. doi: 10.1016/j.lpm.2018.06.013. Epub 2018 Sep 13. French.

2.

Seroprevalence of Zika virus and Rubella virus IgG among blood donors in Rwanda and in Sweden.

Seruyange E, Gahutu JB, Muvunyi CM, Katare S, Ndahindwa V, Sibomana H, Nyamusore J, Rutagarama F, Hannoun C, Norder H, Bergström T.

J Med Virol. 2018 Aug;90(8):1290-1296. doi: 10.1002/jmv.25198. Epub 2018 Jun 6.

PMID:
29663453
3.

Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.

Larsson SB, Malmström S, Hannoun C, Norkrans G, Lindh M.

Virol J. 2015 Dec 9;12:213. doi: 10.1186/s12985-015-0447-5.

4.

Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus.

Lundin A, Dijkman R, Bergström T, Kann N, Adamiak B, Hannoun C, Kindler E, Jónsdóttir HR, Muth D, Kint J, Forlenza M, Müller MA, Drosten C, Thiel V, Trybala E.

PLoS Pathog. 2014 May 29;10(5):e1004166. doi: 10.1371/journal.ppat.1004166. eCollection 2014 May.

5.

Norovirus GII.4 detection in environmental samples from patient rooms during nosocomial outbreaks.

Nenonen NP, Hannoun C, Svensson L, Torén K, Andersson LM, Westin J, Bergström T.

J Clin Microbiol. 2014 Jul;52(7):2352-8. doi: 10.1128/JCM.00266-14. Epub 2014 Apr 23.

6.

HBsAg quantification for identification of liver disease in chronic hepatitis B virus carriers.

Larsson SB, Eilard A, Malmström S, Hannoun C, Dhillon AP, Norkrans G, Lindh M.

Liver Int. 2014 Aug;34(7):e238-45. doi: 10.1111/liv.12345. Epub 2013 Oct 25.

PMID:
24118747
7.

The evolving history of influenza viruses and influenza vaccines.

Hannoun C.

Expert Rev Vaccines. 2013 Sep;12(9):1085-94. doi: 10.1586/14760584.2013.824709. Epub 2013 Sep 12. Review.

PMID:
24024871
8.

Comparison between terminal-restriction fragment length polymorphism (T-RFLP) and quantitative culture for analysis of infants' gut microbiota.

Sjöberg F, Nowrouzian F, Rangel I, Hannoun C, Moore E, Adlerberth I, Wold AE.

J Microbiol Methods. 2013 Jul;94(1):37-46. doi: 10.1016/j.mimet.2013.04.002. Epub 2013 Apr 11.

PMID:
23583598
9.

Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.

Malmström S, Larsson SB, Hannoun C, Lindh M.

PLoS One. 2012;7(7):e36349. doi: 10.1371/journal.pone.0036349. Epub 2012 Jul 20.

10.

Genotype impact on long-term virological outcome of chronic hepatitis B virus infection.

Malmström S, Eilard A, Larsson SB, Hannoun C, Norkrans G, Lindh M.

J Clin Virol. 2012 Aug;54(4):321-6. doi: 10.1016/j.jcv.2012.04.015. Epub 2012 May 18.

PMID:
22608364
11.

Marked genomic diversity of norovirus genogroup I strains in a waterborne outbreak.

Nenonen NP, Hannoun C, Larsson CU, Bergström T.

Appl Environ Microbiol. 2012 Mar;78(6):1846-52. doi: 10.1128/AEM.07350-11. Epub 2012 Jan 13.

12.

Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam--genotypes B4 and C1 predominate.

Phung TB, Alestig E, Nguyen TL, Hannoun C, Lindh M.

J Med Virol. 2010 Aug;82(8):1327-33. doi: 10.1002/jmv.21775.

PMID:
20572069
13.

Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximab.

Barbier A, Domont J, Magné N, Goldmard JL, Genestie C, Hannoun C, Vaillant JC, Bellanger A, Khayat D, Capron F, Spano JP.

Bull Cancer. 2010 Feb;97(2):E9-E15. doi: 10.1684/bdc.2010.1033.

14.

Molecular analysis of an oyster-related norovirus outbreak.

Nenonen NP, Hannoun C, Olsson MB, Bergström T.

J Clin Virol. 2009 Jun;45(2):105-8. doi: 10.1016/j.jcv.2009.04.011. Epub 2009 May 17.

PMID:
19451026
15.

[Natural history of influenza].

Hannoun C.

Rev Prat. 2008 Oct 15;58(15):1645-54. French.

PMID:
19044047
16.

Colonization dynamics of ampicillin-resistant Escherichia coli in the infantile colonic microbiota.

Karami N, Hannoun C, Adlerberth I, Wold AE.

J Antimicrob Chemother. 2008 Oct;62(4):703-8. doi: 10.1093/jac/dkn263. Epub 2008 Jun 25.

PMID:
18583327
17.

Tracing of norovirus outbreak strains in mussels collected near sewage effluents.

Nenonen NP, Hannoun C, Horal P, Hernroth B, Bergström T.

Appl Environ Microbiol. 2008 Apr;74(8):2544-9. doi: 10.1128/AEM.02477-07. Epub 2008 Feb 29.

18.

Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR.

Malmström S, Hannoun C, Lindh M.

J Virol Methods. 2007 Aug;143(2):147-52. Epub 2007 Apr 9.

PMID:
17416427
19.

Lamivudine resistance of hepatitis B virus masked by coemergence of mutations in probe region of the COBAS AMPLICOR assay.

Lindh M, Hannoun C, Malmström S, Lindberg J, Norkrans G.

J Clin Microbiol. 2006 Jul;44(7):2587-9.

20.

Detection of hepatitis A virus genotype IB variants in clams from Maputo Bay, Mozambique.

Nenonen NP, Hernroth B, Chauque AA, Hannoun C, Bergström T.

J Med Virol. 2006 Jul;78(7):896-905.

PMID:
16721847
21.

Genotyping of hepatitis C virus by Taqman real-time PCR.

Lindh M, Hannoun C.

J Clin Virol. 2005 Oct;34(2):108-14.

PMID:
16157261
23.
24.

Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals.

Hass M, Hannoun C, Kalinina T, Sommer G, Manegold C, Günther S.

Hepatology. 2005 Jul;42(1):93-103.

PMID:
15962285
25.

Immunogenicity and protective efficacy of influenza vaccination.

Hannoun C, Megas F, Piercy J.

Virus Res. 2004 Jul;103(1-2):133-8. Review. No abstract available.

PMID:
15163501
26.

Case definition for influenza surveillance.

Hannoun C.

Eur J Epidemiol. 2003;18(8):737-8. No abstract available.

PMID:
12974545
27.

Simple method for detection of mutations causing hereditary fructose intolerance.

Kullberg-Lindh C, Hannoun C, Lindh M.

J Inherit Metab Dis. 2002 Nov;25(7):571-5.

PMID:
12638940
28.

Plans against influenza pandemics in Europe: history and principles.

Hannoun C.

Euro Surveill. 1998 Mar;3(3):26-28.

PMID:
12631778
29.

Genotype mixtures of hepatitis B virus in patients treated with interferon.

Hannoun C, Krogsgaard K, Horal P, Lindh M; Interpred trial group.

J Infect Dis. 2002 Sep 15;186(6):752-9. Epub 2002 Aug 28.

PMID:
12198608
30.
31.

Hepatitis B virus genotypes in Mongols and Australian Aborigines.

Alestig E, Hannoun C, Horal P, Lindh M.

Arch Virol. 2001 Dec;146(12):2321-9.

PMID:
11811682
32.

Mutations in the X region and core promoter are rare and have little impact on response to interferon therapy for chronic hepatitis B.

Hannoun C, Horal P, Krogsgaard K, Lindh M; INTERPRED Study Group.

J Med Virol. 2002 Feb;66(2):171-8.

PMID:
11782925
33.

Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay.

Lindh M, Hannoun C, Horal P, Krogsgaard K; Interpred Study Group.

J Viral Hepat. 2001 Sep;8(5):349-57.

PMID:
11555192
34.

Phylogenetic origin of hepatitis B virus strains with precore C-1858 variant.

Alestig E, Hannoun C, Horal P, Lindh M.

J Clin Microbiol. 2001 Sep;39(9):3200-3.

35.

Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.

Manegold C, Hannoun C, Wywiol A, Dietrich M, Polywka S, Chiwakata CB, Günther S.

Clin Infect Dis. 2001 Jan;32(1):144-8. Epub 2000 Dec 13.

PMID:
11118394
36.

An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam.

Hannoun C, Norder H, Lindh M.

J Gen Virol. 2000 Sep;81(Pt 9):2267-72.

PMID:
10950984
37.

Le bilan de deux siecles d'exploits de la vaccination.

Hannoun C.

Arch Pediatr. 2000 May;7 Suppl 2:279s. French. No abstract available.

PMID:
10904741
38.
39.

Long-term mutation rates in the hepatitis B virus genome.

Hannoun C, Horal P, Lindh M.

J Gen Virol. 2000 Jan;81(Pt 1):75-83.

PMID:
10640544
40.

Production of influenza virus in serum-free mammalian cell cultures.

Merten OW, Manuguerra JC, Hannoun C, van der Werf S.

Dev Biol Stand. 1999;98:23-37; discussion 73-4.

PMID:
10494957
41.

Private or national health insurance for adult vaccination in developed countries?

Hannoun C.

Vaccine. 1999 Jul 30;17 Suppl 1:S99-101. No abstract available.

PMID:
10471191
42.

Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers.

Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P.

J Infect Dis. 1999 Apr;179(4):775-82.

PMID:
10068571
43.

Study of the O-acetylesterase activity of five influenza C virus strains.

Sánchez-Bernal C, Muñoz-Barroso I, Manuguerra JC, Hannoun C, Cabezas JA.

Arch Virol. 1998;143(9):1783-90.

PMID:
9787661
44.

Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments.

Ramisse F, Deramoudt FX, Szatanik M, Bianchi A, Binder P, Hannoun C, Alonso JM.

Clin Exp Immunol. 1998 Mar;111(3):583-7.

45.

Influenza vaccination in 22 developed countries: an update to 1995.

Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jørgensen K, Ahlbom AM, Nøkleby H, Valle M, Olafsson O, Salmerón F, Cloetta J, Rebelo de Andrade H, Snacken R, Donatelli I, Jennings LC, Strikas RA.

Vaccine. 1997 Oct;15(14):1506-11.

PMID:
9330460
46.

[Influenza: interspecies transmissions and viral rearrangement].

Manuguerra JC, Hannoun C.

Bull Acad Natl Med. 1997 Mar 18;181(3):421-30. Review. French.

PMID:
9244574
47.

Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs.

Brown IH, Ludwig S, Olsen CW, Hannoun C, Scholtissek C, Hinshaw VS, Harris PA, McCauley JW, Strong I, Alexander DJ.

J Gen Virol. 1997 Mar;78 ( Pt 3):553-62.

PMID:
9049404
48.

European Journal of Epidemiology expands in 1997 for those who believe in the future of epidemiology.

Hannoun C.

Eur J Epidemiol. 1997 Feb;13(2):V. No abstract available.

PMID:
9084992
49.

Production of influenza virus in cell cultures for vaccine preparation.

Merten OW, Hannoun C, Manuguerra JC, Ventre F, Petres S.

Adv Exp Med Biol. 1996;397:141-51.

PMID:
8718593
50.

Influenza vaccination in 18 developed countries, 1980-1992.

Fedson DS, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jørgensen K, Ahlbom AM, Nøkelby H, Valle M, Olafsson O, et al.

Vaccine. 1995 May;13(7):623-7.

PMID:
7668032

Supplemental Content

Loading ...
Support Center